VSee Health, Inc.(VSEEW)Earnings, Financials & Key Ratios
VSEEW•NASDAQ
$0.04
$612817 mkt cap·Price updated May 7, 2026
AboutVSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.Show more
- Revenue$10M+78.4%
- EBITDA-$61M-4030.6%
- Net Income-$58M-1573.4%
- EPS (Diluted)-5.65-572.6%
- Gross Margin68.87%+2.9%
- EBITDA Margin-583.15%-2215.1%
- Operating Margin-596.38%-2266.5%
- Net Margin-553.69%-837.9%
- ROIC-1500.09%
- Interest Coverage-293.91-43395.3%
VSEEW Key Insights
VSee Health, Inc. (VSEEW) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
VSEEW Price & Volume
VSee Health, Inc. (VSEEW) stock price & volume — 10-year historical chart
Loading chart...
VSEEW Growth Metrics
VSee Health, Inc. (VSEEW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years12.41%
TTM80.43%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM77.12%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM92.96%
Return on Capital
10 Years-1752.34%
5 Years-1752.34%
3 Years-3554%
Last Year-6327.92%
VSEEW Peer Comparison
VSee Health, Inc. (VSEEW) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TDOC | 1.26B | 6.96 | -6.11 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 129.49M | 7.75 | -1.30 | -1.98% | -48.16% | -33.48% | 0.02 | |
 OPRX | 123.59M | 6.63 | 24.56 | 18.78% | 4.69% | 4.22% | 0.04 | |
 TALK | 867.72M | 5.18 | 129.50 | 22% | 3.4% | 6.89% | ||
 HIMS | 6.63B | 25.67 | 50.32 | 59% | 5.47% | 23.73% | 2.07 | |
 DOCS | 5.24B | 26.03 | 23.45 | 19.98% | 37.54% | 24.45% | 0.01 | |
 PHVS | 1.93B | 29.68 | -10.18 | -53.18% | 0.00 | |||
 WELL | 149.25B | 213.02 | 153.25 | 35.82% | 12.31% | 3.49% | 0.49 |
Compare VSEEW vs Peers
VSee Health, Inc. (VSEEW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
VSEEW Income Statement
VSee Health, Inc. (VSEEW) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Sales/Revenue | 6.8M | 7.34M | 6.38M | 5.84M | 10.42M | 14.55M |
| Revenue Growth % | - | 7.82% | -13.08% | -8.42% | 78.42% | 80.43% |
| Cost of Goods Sold | 1.34M | 1.41M | 1.54M | 1.93M | 3.24M | 6.6M |
| COGS % of Revenue | 19.7% | 19.26% | 24.19% | 33.1% | 31.13% | - |
| Gross Profit | 5.46M▲ 0% | 5.92M▲ 8.4% | 4.84M▼ 18.4% | 3.91M▼ 19.2% | 7.18M▲ 83.7% | 7.95M▲ 0% |
| Gross Margin % | 80.3% | 80.74% | 75.81% | 66.9% | 68.87% | 54.64% |
| Gross Profit Growth % | - | 8.41% | -18.38% | -19.18% | 83.68% | - |
| Operating Expenses | 5.06M | 5.67M | 3.59M | 5.47M | 69.33M | 17.43M |
| OpEx % of Revenue | 74.36% | 77.3% | 56.37% | 93.59% | 665.25% | - |
| Selling, General & Admin | 5.06M | 5.67M | 3.59M | 5.38M | 11.86M | 15.83M |
| SG&A % of Revenue | 74.36% | 77.3% | 56.37% | 92.1% | 113.81% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 156.52K | 86.8K | 57.47M | 1.59M |
| Operating Income | 404.5K▲ 0% | 252.28K▼ 37.6% | -3.59M▼ 1525.0% | -1.47M▲ 59.1% | -62.15M▼ 4122.3% | -9.47M▲ 0% |
| Operating Margin % | 5.94% | 3.44% | -56.37% | -25.2% | -596.38% | -65.1% |
| Operating Income Growth % | - | -37.63% | -1524.99% | 59.06% | -4122.35% | - |
| EBITDA | 0 | 0 | -2.13M | -1.47M | -60.77M | -6.08M |
| EBITDA Margin % | - | - | -33.41% | -25.19% | -583.15% | -41.79% |
| EBITDA Growth % | - | - | - | 30.96% | -4030.57% | 89.38% |
| D&A (Non-Cash Add-back) | -404.5K | -252.28K | 1.46M | 678 | 1.38M | 3.39M |
| EBIT | 404.5K | 252.28K | -2.93M | -2.24M | -59.13M | -9.97M |
| Net Interest Income | 45.03K | 0 | -31.87K | -1.82M | -211.46K | -1.73M |
| Interest Income | 45.03K | 0 | 0 | 358.77K | 0 | 0 |
| Interest Expense | 0 | 0 | 31.87K | 2.18M | 211.46K | 1.73M |
| Other Income/Expense | -45.03K | 134.06K | 59.92K | -100.17K | 2.81M | -1.84M |
| Pretax Income | 359.47K▲ 0% | 386.34K▲ 7.5% | -3.06M▼ 890.8% | -1.57M▲ 48.5% | -59.34M▼ 3674.8% | -11.31M▲ 0% |
| Pretax Margin % | 5.28% | 5.27% | -47.91% | -26.92% | -569.46% | -77.75% |
| Income Tax | 100.59K | 108.11K | 187.22K | 1.84M | -1.64M | 1.17M |
| Effective Tax Rate % | 27.98% | 27.98% | -6.13% | -116.94% | 2.77% | -10.31% |
| Net Income | 258.88K▲ 0% | 475.9K▲ 83.8% | -3.24M▼ 781.3% | -3.45M▼ 6.3% | -57.7M▼ 1573.4% | -12.48M▲ 0% |
| Net Margin % | 3.8% | 6.49% | -50.84% | -59.03% | -553.69% | -85.76% |
| Net Income Growth % | - | 83.83% | -781.34% | -6.34% | -1573.45% | 77.12% |
| Net Income (Continuing) | 258.88K | 278.23K | -3.24M | -4.41M | -57.7M | -12.48M |
| Discontinued Operations | 0 | 0 | 0 | 37.48K | 0 | 0 |
| Minority Interest | 0 | -273.21K | -362.75K | -325.28K | 0 | 0 |
| EPS (Diluted) | 0.02▲ 0% | -0.02▼ 208.7% | -0.25▼ 1229.8% | -0.84▼ 236.0% | -5.65▼ 572.6% | -0.75▲ 0% |
| EPS Growth % | - | -208.67% | -1229.79% | -236% | -572.62% | 92.96% |
| EPS (Basic) | 0.02 | -0.02 | -0.25 | -0.84 | -5.65 | - |
| Diluted Shares Outstanding | 14.93M | 14.93M | 12.74M | 4.12M | 10.21M | 16.55M |
| Basic Shares Outstanding | 14.93M | 14.93M | 12.74M | 4.12M | 10.21M | 16.55M |
| Dividend Payout Ratio | - | - | - | - | - | - |
VSEEW Balance Sheet
VSee Health, Inc. (VSEEW) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Total Current Assets | 1.48M | 777.75K | 759.78K | 827.13K | 3.02M | 3.72M |
| Cash & Short-Term Investments | 775.24K | 346.44K | 230.66K | 118.73K | 326.12K | 472.76K |
| Cash Only | 775.24K | 346.44K | 230.66K | 118.73K | 326.12K | 472.76K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 659.04K | 286.09K | 389.45K | 628.48K | 2.25M | 2.58M |
| Days Sales Outstanding | 35.35 | 14.23 | 22.29 | 39.27 | 78.74 | 52.01 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 0 | 145.22K | 0 | 0 | 446.83K | 667.14K |
| Total Non-Current Assets | 1.25M | 1.16M | 1.85M | 3.66K | 16.97M | 14.99M |
| Property, Plant & Equipment | 0 | 0 | 0 | 3.66K | 1.06M | 734.54K |
| Fixed Asset Turnover | - | - | - | 1597.18x | 9.83x | 16.19x |
| Goodwill | 0 | 0 | 0 | 0 | 4.92M | 4.92M |
| Intangible Assets | 0 | 0 | 0 | 0 | 10.99M | 9.34M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.25M | 0 | 1.85M | 0 | 0 | 0 |
| Total Assets | 2.73M▲ 0% | 1.94M▼ 29.0% | 2.61M▲ 34.9% | 830.79K▼ 68.2% | 19.99M▲ 2306.4% | 18.71M▲ 0% |
| Asset Turnover | 2.50x | 3.79x | 2.44x | 7.03x | 0.52x | 0.76x |
| Asset Growth % | - | -28.99% | 34.93% | -68.2% | 2306.44% | 3534.5% |
| Total Current Liabilities | 2.11M | 1.01M | 2.61M | 4.24M | 19.01M | 23.42M |
| Accounts Payable | 311.24K | 202.45K | 687.82K | 187.22K | 4.28M | 0 |
| Days Payables Outstanding | 84.75 | 52.28 | 162.74 | 35.35 | 481.98 | 59.22 |
| Short-Term Debt | 133.08K | 0 | 517.13K | 543K | 8.28M | 2.67M |
| Deferred Revenue (Current) | 0 | 810.05K | 0 | 0 | 417.81K | 3.58M |
| Other Current Liabilities | 1.67M | 0 | 1.23M | 2M | 2.51M | 19.6M |
| Current Ratio | 0.70x | 0.77x | 0.29x | 0.19x | 0.16x | 0.16x |
| Quick Ratio | 0.70x | 0.77x | 0.29x | 0.19x | 0.16x | 0.16x |
| Cash Conversion Cycle | - | - | - | - | - | -7.21 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 4.37M | 1M | 860.44K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 793.06K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 863.28K | 863.28K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 67.38K | 269.51K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 4.37M | 0 | 0 |
| Total Liabilities | 2.11M | 1.01M | 2.61M | 4.24M | 20.01M | 24.28M |
| Total Debt | 133.08K | 0 | 517.13K | 543K | 9.55M | 3.46M |
| Net Debt | -642.16K | -346.44K | 286.47K | 424.27K | 9.22M | 2.99M |
| Debt / Equity | 0.22x | - | - | - | - | -0.62x |
| Debt / EBITDA | - | - | - | - | - | -0.57x |
| Net Debt / EBITDA | - | - | - | - | - | -0.49x |
| Interest Coverage | - | - | -112.81x | -0.68x | -293.91x | -5.77x |
| Total Equity | 614.49K▲ 0% | 923.72K▲ 50.3% | -2.03K▼ 100.2% | -3.41M▼ 167762.6% | -18.49K▲ 99.5% | -5.58M▲ 0% |
| Equity Growth % | - | 50.32% | -100.22% | -167762.62% | 99.46% | -231.41% |
| Book Value per Share | 0.04 | 0.06 | -0.00 | -0.83 | -0.00 | -0.34 |
| Total Shareholders' Equity | 614.49K | 1.2M | 360.72K | -3.09M | -18.49K | -5.58M |
| Common Stock | 985 | 1K | 1K | 1K | 1.63K | 31.23K |
| Retained Earnings | -5.38M | -4.83M | -5.67M | -9.11M | -67.7M | -74.57M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | -273.21K | -362.75K | -325.28K | 0 | 0 |
VSEEW Cash Flow Statement
VSee Health, Inc. (VSEEW) cash flow — operating, investing & free cash flow history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Cash from Operations | 789.12K | -600.11K | -1.45M | -632.6K | -5.79M | -5.79M |
| Operating CF Margin % | 11.6% | -8.18% | -22.78% | -10.83% | -55.55% | - |
| Operating CF Growth % | - | -176.05% | -142.12% | 56.46% | -815.21% | -1042.04% |
| Net Income | 258.88K | -280.7K | -3.24M | -3.73M | -57.7M | -12.48M |
| Depreciation & Amortization | 0 | 0 | 0 | 678 | 1.38M | 2.72M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 896.54K | 515.45K |
| Deferred Taxes | 0 | 0 | 0 | 1.85M | -1.68M | 657.1K |
| Other Non-Cash Items | 1.16M | -1.97K | -727.47K | -71.87K | 54.52M | 3.06M |
| Working Capital Changes | -629.07K | -317.44K | 2.52M | 1.31M | -3.21M | 1.03M |
| Change in Receivables | -604.06K | 0 | 0 | -246.48K | -839.81K | -2M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 1.41M | -1.45M | 2.07M |
| Cash from Investing | 0 | -116.73M | 110.12M | -4.33K | -26.14K | -27.54K |
| Capital Expenditures | 0 | 0 | 0 | -4.33K | -55.27K | -27.54K |
| CapEx % of Revenue | - | 0% | 0% | 0.07% | 0.53% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 29.12K | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 110.47M | 0 | 0 | 0 |
| Cash from Financing | -83.67K | 118.09M | -109.32M | 525K | 6.02M | 2.67M |
| Debt Issued (Net) | 0 | -452.77K | 1.15M | 390K | 4.75M | 2.19M |
| Equity Issued (Net) | 0 | -121K | -1000K | 0 | 0 | 531.18K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -110.47M | 0 | 0 | 0 |
| Other Financing | -83.67K | 118.66M | 0 | 135K | 1.27M | -58.89K |
| Net Change in Cash | 705.45K▲ 0% | 760.01K▲ 7.7% | -653.01K▼ 185.9% | -111.93K▲ 82.9% | 207.38K▲ 285.3% | -1.85M▲ 0% |
| Free Cash Flow | 789.12K▲ 0% | -600.11K▼ 176.0% | -1.45M▼ 142.1% | -636.93K▲ 56.2% | -5.84M▼ 817.7% | -4.52M▲ 0% |
| FCF Margin % | 11.6% | -8.18% | -22.78% | -10.9% | -56.08% | -31.07% |
| FCF Growth % | - | -176.05% | -142.12% | 56.16% | -817.65% | -42.23% |
| FCF per Share | 0.05 | -0.04 | -0.11 | -0.15 | -0.57 | -0.57 |
| FCF Conversion (FCF/Net Income) | 3.05x | -1.26x | 0.45x | 0.18x | 0.10x | 0.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 111.33K | -6.74K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | -320 |
VSEEW Key Ratios
VSee Health, Inc. (VSEEW) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Return on Equity (ROE) | 61.88% | -703.6% | - | - | 336.68% |
| Return on Invested Capital (ROIC) | 68.85% | -625.78% | - | -1500.09% | -1500.09% |
| Gross Margin | 80.74% | 75.81% | 66.9% | 68.87% | 54.64% |
| Net Margin | 6.49% | -50.84% | -59.03% | -553.69% | -85.76% |
| Debt / Equity | - | - | - | - | -0.62x |
| Interest Coverage | - | -112.81x | -0.68x | -293.91x | -5.77x |
| FCF Conversion | -1.26x | 0.45x | 0.18x | 0.10x | 0.36x |
| Revenue Growth | 7.82% | -13.08% | -8.42% | 78.42% | 80.43% |
VSEEW Frequently Asked Questions
VSee Health, Inc. (VSEEW) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
VSee Health, Inc. (VSEEW) reported $14.6M in revenue for fiscal year 2024. This represents a 114% increase from $6.8M in 2020.
VSee Health, Inc. (VSEEW) grew revenue by 78.4% over the past year. This is strong growth.
VSee Health, Inc. (VSEEW) reported a net loss of $12.5M for fiscal year 2024.
Dividend & Returns
VSee Health, Inc. (VSEEW) had negative free cash flow of $4.5M in fiscal year 2024, likely due to heavy capital investments.
Explore More VSEEW
VSee Health, Inc. (VSEEW) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates